CO5050298A1 - Metodo y composicion para tratar impotencia - Google Patents

Metodo y composicion para tratar impotencia

Info

Publication number
CO5050298A1
CO5050298A1 CO99030405A CO99030405A CO5050298A1 CO 5050298 A1 CO5050298 A1 CO 5050298A1 CO 99030405 A CO99030405 A CO 99030405A CO 99030405 A CO99030405 A CO 99030405A CO 5050298 A1 CO5050298 A1 CO 5050298A1
Authority
CO
Colombia
Prior art keywords
composition
dinitrate
topical
treat impotence
impotence
Prior art date
Application number
CO99030405A
Other languages
English (en)
Inventor
Selim Sami
Robert Testman
Leung Fung Ho
John A Bauer
Original Assignee
Baker Norton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Norton Pharma filed Critical Baker Norton Pharma
Publication of CO5050298A1 publication Critical patent/CO5050298A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

Composiciones farmacéuticas en forma tópica o parenteral, quecontienen moninitratos dinitratos orgánicos específicos, algunos de ellos compuestos novedosos, son efectivas para tratar impotencia masculina y disfunción eréctil a través de administración tópica o intracavernosa al pene. También se exponen métodos de tratamiento que utilizan las composiciones que contienen mononitrato o dinitrato.
CO99030405A 1998-05-18 1999-05-18 Metodo y composicion para tratar impotencia CO5050298A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/081,108 US6056966A (en) 1998-05-18 1998-05-18 Method and compositions for treating impotence

Publications (1)

Publication Number Publication Date
CO5050298A1 true CO5050298A1 (es) 2001-06-27

Family

ID=22162141

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99030405A CO5050298A1 (es) 1998-05-18 1999-05-18 Metodo y composicion para tratar impotencia

Country Status (17)

Country Link
US (1) US6056966A (es)
EP (1) EP1079823A1 (es)
JP (1) JP2003511343A (es)
KR (1) KR20010071283A (es)
CN (1) CN1307472A (es)
AR (1) AR018861A1 (es)
AU (1) AU758035B2 (es)
BR (1) BR9911060A (es)
CA (1) CA2332328A1 (es)
CO (1) CO5050298A1 (es)
HU (1) HUP0101668A2 (es)
IL (1) IL139751A0 (es)
NO (1) NO20005793L (es)
PL (1) PL344335A1 (es)
SK (1) SK17452000A3 (es)
WO (1) WO1999059575A1 (es)
ZA (1) ZA200006733B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
AU2001278981A1 (en) * 2000-07-21 2002-02-05 Tom F Lue Prevention and treatment of sexual arousal disorders
CA2473097A1 (en) * 2002-01-11 2003-07-17 David R. Whitlock Compositions including ammonia oxidizing bacteria and methods of using same
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
CA2539974A1 (en) * 2003-09-26 2005-04-07 David R. Whitlock Methods of using ammonia oxidizing bacteria
US7507842B2 (en) 2005-08-12 2009-03-24 Radiorx, Inc. Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
US20070135380A1 (en) * 2005-08-12 2007-06-14 Radiorx, Inc. O-nitro compounds, pharmaceutical compositions thereof and uses thereof
US20070175484A1 (en) * 2006-01-30 2007-08-02 Staab Robert J Condoms for beneficial agents delivery
US8212735B2 (en) * 2009-06-05 2012-07-03 Nokia Corporation Near field communication
WO2011057386A1 (en) * 2009-11-13 2011-05-19 Oral Delivery Technology Ltd. Composition and prophylactic device for enhancing sexual performance or pleasure
US9023890B2 (en) 2009-12-02 2015-05-05 The Charlotte-Mecklenburg Hospital Authority Nitrate esters and their use for the treatment of muscle and muscle related diseases
US8471041B2 (en) * 2010-02-09 2013-06-25 Alliant Techsystems Inc. Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
US9452117B2 (en) 2011-06-01 2016-09-27 The Charlotte-Mecklenburg Hospital Authority Nitrate esters and their use for the treatment of muscle and muscle related diseases
US8664247B2 (en) 2011-08-26 2014-03-04 Radiorx, Inc. Acyclic organonitro compounds for use in treating cancer
ES2935573T3 (es) 2011-10-07 2023-03-08 Epicentrx Inc Compuestos de organonitro tioéter y usos médicos de estos
US20140308260A1 (en) 2011-10-07 2014-10-16 Radiorx, Inc. Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
CN104352436A (zh) * 2014-10-09 2015-02-18 南京泽恒医药技术开发有限公司 一种硝酸甘油原位成形凝胶喷雾剂及其制备方法
US10342778B1 (en) 2015-10-20 2019-07-09 Epicentrx, Inc. Treatment of brain metastases using organonitro compound combination therapy
US9987270B1 (en) 2015-10-29 2018-06-05 Epicentrix, Inc. Treatment of gliomas using organonitro compound combination therapy
SG11201805942UA (en) 2016-01-11 2018-08-30 Epicentrx Inc Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone
AU2017342436C1 (en) 2016-10-14 2022-11-03 Epicentrx, Inc. Sulfoxyalkyl organonitro and related compounds and pharmaceutical compositions for use in medicine
IL271777B2 (en) 2017-07-07 2024-09-01 Epicentrx Inc Preparations for intravenous administration of medical substances
US11510901B2 (en) 2018-01-08 2022-11-29 Epicentrx, Inc. Methods and compositions utilizing RRx-001 combination therapy for radioprotection
RU2757309C1 (ru) * 2020-11-02 2021-10-13 Ассим Абдель Гани Ахмед Сонбол Композиция для коррекции сексуальной дисфункции у мужчин

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4112115A (en) * 1976-11-08 1978-09-05 Coghlan Charles C Therapy of leg muscle cramps
US4913469A (en) * 1988-08-08 1990-04-03 Cameron Iron Works Usa, Inc. Wellhead slip and seal assembly
NL8802276A (nl) * 1988-09-15 1990-04-02 Cedona Pharm Bv Geneesmiddel met relaxerende werking, dat als aktieve stof een nitraatester bevat.
JPH02200633A (ja) * 1989-01-27 1990-08-08 Akamatsu Shoji Kk 血管拡張剤
US5059603A (en) * 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition
US5646181A (en) * 1992-07-02 1997-07-08 Research Foundation Of State University Of New York Method and compositions for treating impotence
WO1994021248A1 (de) * 1993-03-15 1994-09-29 Byk Nederland Bv Verwendung von substituierten alkylnitraten zur behandlung des krankhaft erhöhten augeninnendruckes
JPH10505611A (ja) * 1995-03-14 1998-06-02 ヴィヴァス・インコーポレーテッド 勃起機能不全を予防するための方法およびキット
ES2257813T3 (es) * 1997-06-23 2006-08-01 Cellegy Pharmaceuticals, Inc Terapia de microdosis de condiciones vasculares mediante donadores de no.

Also Published As

Publication number Publication date
AU758035B2 (en) 2003-03-13
HUP0101668A2 (hu) 2001-10-28
AU4000699A (en) 1999-12-06
WO1999059575A1 (en) 1999-11-25
CN1307472A (zh) 2001-08-08
ZA200006733B (en) 2001-09-18
NO20005793D0 (no) 2000-11-16
US6056966A (en) 2000-05-02
BR9911060A (pt) 2001-02-06
CA2332328A1 (en) 1999-11-25
EP1079823A1 (en) 2001-03-07
PL344335A1 (en) 2001-11-05
AR018861A1 (es) 2001-12-12
JP2003511343A (ja) 2003-03-25
IL139751A0 (en) 2002-02-10
KR20010071283A (ko) 2001-07-28
NO20005793L (no) 2001-01-17
SK17452000A3 (sk) 2001-08-06

Similar Documents

Publication Publication Date Title
CO5050298A1 (es) Metodo y composicion para tratar impotencia
AR002992A1 (es) Composicion farmaceutica para el tratamiento de la impotencia masculina o disminucion erectil y aplicacion de un nitrito organico con este fin.
ATE245650T1 (de) Pyrazolopyimidinon-derivate zur behandlung von impotenz
GB9807639D0 (en) Anti-inflammatory agents
MX9703868A (es) Inhibidores de cgmp-pde para el tratamiento de disfuncion erectil.
HK1091418A1 (en) Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
ECSP045153A (es) Metodo y composición para aumentar la potencia de un analgésico de narcotico.
MX9400434A (es) Potenciamiento de temozolomida en celulas de tumores humanos.
DE69739970D1 (de) Methode zur behandlung sexueller fehlfunktionen
DK1109814T3 (da) 5-Heterocyclylpyrazolo[4,3-d]pyrimidin-7-oner til behandling af mandlig erektil dysfunktion
IL151692A0 (en) Polyamine analogues as cytotoxic agents
ATE453402T1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
BR0110844A (pt) Composição e processo para tratar plantas
ES2172171T3 (es) Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles.
MXPA03004288A (es) Tratamiento de disfuncion sexual inducida por farmaco antidepresivo con apomorfina.
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
ES2099293T3 (es) Compuestos de piridilguanidina para el tratamiento de la disfuncion erectil.
ES2196069T3 (es) Derivados morfinoides condensados con heterociclos.
ES2184300T3 (es) Derivados de aminoacidos utiles para tratar el accidente vascular encefalico.
AR019327A1 (es) Combinacion de fentolamina y apomorfina para el tratamiento de la funcion y disfuncion sexual humana
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
AR020815A1 (es) Procedimiento para el tratamiento de la esquizofrenia, como tambien medios para ser utilizados en dicho procedimiento
ECSP993026A (es) Combinacion de fentolamina y apomorfina para el tratamiento de la funcion y disfuncion sexual humana
CO5251415A1 (es) Matodo para tratar sintomas de migrana
TW200510374A (en) Benzimidazoles that are useful in treating sexual dysfunction